Trials / Completed
CompletedNCT01811511
Efficacy and Safety of Chungkookjang on Improvement of Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 29 Years
- Healthy volunteers
- Accepted
Summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled crossover human trial to evaluate the efficacy and safety of chungkookjang on improvement of metabolic syndrome. The investigators measured decrement of body fat parameters, including Body Fat Mass, Percent Body Fat, Fat Free Mass, Weight and BMI(body mass index), and monitored their blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Chungkookjang | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Completion
- 2014-02-01
- First posted
- 2013-03-14
- Last updated
- 2015-02-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01811511. Inclusion in this directory is not an endorsement.